Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy

Chemotherapy is one of the conventional treatments for cancer in clinical practice.However,poor delivery efficiency,systemic toxicity,and the lack of pharmacokinetic monitoring during treatment are the critical limitations of current chemotherapy.Herein,we reported a brand-new antitumor drug delivery strategy that harnesses an optical fiber endoscopically therapeutic probe.The fiber probe carries photosensitizers in the fiber core and antitumor agents on the fiber surface mediated by a temperature-responsive hydrogel film,giving rise to an activable photothermalchemotherapy that orchestrates the localized hyperthermia and thermal-stimuli drug release to the tumor lesion.Furthermore,the dynamical drug release and in-situ temperature can be real-time supervised through the built-in fiber sensors,including the reflective Mach–Zehnder interferometer and fiber Bragg grating,to visualize the therapy process and thus improve the safety of treatment.Compared with conventional methods,the fiber-optic drug delivery can adequately take advantage of the chemotherapeutics through collaboratively recruiting the photoheating-mediated enhanced permeability and the hydrogel particle-assisted high drug retention,shedding new light on a“central-toperipheral”drug pervasion and retention mechanism to destroy tumors completely.The fiber-optic chemotherapy strategy incorporates precise drug delivery,accurate controllability of drug release,high drug permeability and retention in tumor,low off-target rate,and real-time drug release and temperature feedback,performing a straightforward and precise photothermal-chemotherapy pathway.More than that,the proposed strategy holds tremendous promise to provide a revolutionized on-demand drug delivery platform for the highly efficient evaluation and screening of antitumor pharmaceuticals.